Qingdao Baheal Medical Inc. Stock Analysis 301015.SZ

Qingdao Baheal Medical, Inc. engages in the provision of marketing services for pharmaceutical product manufacturers. The company is headquartered in Qingdao, Shandong and currently employs 2,493 full-time employees. The company went IPO on 2021-06-30. The firm operates through three segments. The Branded Product Sales and Promotion segment is primarily engaged in the sales and distribution of various branded products. The Pharmaceutical Wholesale and Distribution segment is primarily engaged in pharmaceutical logistics and distribution, wholesales and distributes pharmaceuticals, medical devices and consumables to hospitals, community clinics and pharmacies. The Pharmaceutical and Health Products Retail segment sells pharmaceuticals and other health products directly to consumers through a combination of offline pharmacies and various online channels. The firm primarily operates in domestic and international markets.